Cardinal Health CAH Business Segments
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cost of product sold | $3.15B-0.4% | $3.26B+3.3% | $3.18B+2.0% | $3.2B+2.9% | $3.16B+1.5% | |
| Other Segments | $1.71B+30.8% | $1.72B+34.4% | $1.64B+38.4% | $1.61B+37.3% | $1.3B+13.0% | |
| Pharmaceutical and Specialty Solutions | $56.11B+11.3% | $60.67B+19.3% | $59.21B+23.4% | $55.37B-0.4% | $50.43B-0.4% | |
| Total Assets by Business | ||||||
| Cost of product sold | $6.89B-4.3% | $6.99B-0.9% | $7.13B-0.2% | $6.89B-2.2% | $7.2B-2.1% | |
| Other Segments | $4.07B+49.1% | $4.07B+49.7% | $4.05B+55.1% | $4.05B+55.2% | $2.73B+1.3% | |
| Pharmaceutical and Specialty Solutions | $41.03B+14.8% | $43.41B+35.1% | $38.68B+32.4% | $37.31B+28.0% | $35.73B+17.2% | |
| Total operating earnings by Business | ||||||
| Cost of product sold | $25M-35.9% | $37M+106% | $46M+475% | $70M+48.9% | $39M+77.3% | |
| Other Segments | $179M+33.6% | $179M+51.7% | $166M+59.6% | $160M+44.1% | $134M+21.8% | |
| Pharmaceutical and Specialty Solutions | $784M+18.4% | $687M+29.4% | $667M+25.8% | $535M+11.0% | $662M+13.7% | |
| Costs and Expenses by Business | ||||||
| Cost of product sold | $3.12B+0.1% | $3.22B+2.7% | $3.14B+0.7% | $3.13B+1.8% | $3.12B+1.6% | |
| Other Segments | $1.53B+30.5% | $1.55B+32.6% | $1.48B+36.3% | $1.45B+41.7% | $1.17B+14.5% | |
| Pharmaceutical and Specialty Solutions | $55.33B+11.2% | $59.98B+19.2% | $58.54B+23.3% | $54.84B+5.5% | $49.77B-4.3% | |
| Cost of products sold by Business | ||||||
| Cost of product sold | $2.61B-1.1% | $2.72B+3.7% | $2.63B+1.1% | $2.61B+1.6% | $2.63B+2.7% | |
| Other Segments | $1.27B+30.1% | $1.29B+33.2% | $1.22B+38.1% | $1.2B+42.0% | $975M+15.8% | |
| Pharmaceutical and Specialty Solutions | $54.6B+11.0% | $59.24B+19.1% | $57.86B+23.3% | $54.17B+5.3% | $49.17B-4.5% | |
| Segment Reporting, Long-Lived Asset, Expenditure for Addition by Business | ||||||
| Cost of product sold | $32M+14.3% | $23M+9.5% | $19M-17.4% | $61M+79.4% | $28M-17.6% | |
| Other Segments | $25M+38.9% | $23M+4.5% | $15M+25.0% | $36M+77.8% | $18M-11.1% | |
| Pharmaceutical and Specialty Solutions | $37M+12.1% | $23M+91.7% | $32M+191% | $62M+226% | $33M+73.7% | |
| D&A by Business | ||||||
| Cost of product sold | $54M-3.6% | $55M-8.3% | $55M+12.2% | $47M-8.3% | $56M+9.3% | |
| Other Segments | $26M-16.1% | $30M-25.0% | $29M+61.1% | $0-100% | $31M+57.0% | |
| Pharmaceutical and Specialty Solutions | $70M+59.1% | $64M+39.1% | $61M+126% | $68M+47.8% | $44M-4.3% | |
| Goodwill by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0— | $0— | |
| Other Segments | $1.75B+49.3% | $1.75B+49.4% | $1.75B+49.1% | $1.75B+49.4% | $1.17B0.0% | |
| Pharmaceutical and Specialty Solutions | $9.67B+25.0% | $9.86B+128% | $7.97B+124% | $7.94B+123% | $7.74B+114% | |
| Distribution, selling, general and administrative expenses by Business | ||||||
| Cost of product sold | $518M+6.4% | $502M-2.0% | $505M-1.2% | $521M+2.9% | $487M-3.8% | |
| Other Segments | $259M+32.8% | $254M+29.6% | $254M+28.3% | $254M+40.7% | $195M+8.0% | |
| Pharmaceutical and Specialty Solutions | $732M+21.2% | $739M+30.1% | $681M+23.6% | $664M+24.1% | $604M+12.9% | |
| Goodwill, Impairment Loss by Business | ||||||
| Pharmaceutical and Specialty Solutions | $184M— | —— | —— | —— | —— | |
| Goodwill, Acquired During Period by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0+100% | $0+100% | |
| Other Segments | -$1M— | $3M— | -$3M— | $578M— | $0— | |
| Revenue by Geography | ||||||
| Non-US | $423M+6.0% | $435M+1.6% | $419M+2.7% | $434M-1.4% | $399M-6.1% | |
| UNITED STATES | $60.54B+11.1% | $65.22B+18.9% | $63.61B+22.6% | $59.75B+0.5% | $54.5B+0.1% | |
| PP&E (Net) by Geography | ||||||
| Non-US | $434M— | $432M— | $435M— | $436M+3.1% | —— | |
| UNITED STATES | $2.49B— | $2.45B— | $2.4B— | $2.42B+15.0% | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
